AU2003283303A1 - Diagnostics and therapeutics for diseases associated with human phosphodiesterase 4b (pde4b) - Google Patents
Diagnostics and therapeutics for diseases associated with human phosphodiesterase 4b (pde4b)Info
- Publication number
- AU2003283303A1 AU2003283303A1 AU2003283303A AU2003283303A AU2003283303A1 AU 2003283303 A1 AU2003283303 A1 AU 2003283303A1 AU 2003283303 A AU2003283303 A AU 2003283303A AU 2003283303 A AU2003283303 A AU 2003283303A AU 2003283303 A1 AU2003283303 A1 AU 2003283303A1
- Authority
- AU
- Australia
- Prior art keywords
- pde4b
- therapeutics
- diagnostics
- diseases associated
- human phosphodiesterase
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57423—Specifically defined cancers of lung
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
- C12Q1/44—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving esterase
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57446—Specifically defined cancers of stomach or intestine
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- Analytical Chemistry (AREA)
- Cell Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Food Science & Technology (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP02024995 | 2002-11-08 | ||
| EP02024995.9 | 2002-11-08 | ||
| PCT/EP2003/011881 WO2004042390A2 (en) | 2002-11-08 | 2003-10-25 | Diagnostics and therapeutics for diseases associated with human phosphodiesterase 4b (pde4b) |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2003283303A8 AU2003283303A8 (en) | 2004-06-07 |
| AU2003283303A1 true AU2003283303A1 (en) | 2004-06-07 |
Family
ID=32309319
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2003283303A Abandoned AU2003283303A1 (en) | 2002-11-08 | 2003-10-25 | Diagnostics and therapeutics for diseases associated with human phosphodiesterase 4b (pde4b) |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU2003283303A1 (en) |
| WO (1) | WO2004042390A2 (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6148007B2 (en) | 2009-05-12 | 2017-06-14 | コーニンクレッカ フィリップス エヌ ヴェＫｏｎｉｎｋｌｉｊｋｅ Ｐｈｉｌｉｐｓ Ｎ．Ｖ． | Phosphodiesterase 4D7 as a prostate cancer marker |
| PE20151332A1 (en) | 2013-02-19 | 2015-09-20 | Pfizer | AZABENZIMIDAZOLE COMPOUNDS |
| JP6713982B2 (en) | 2014-07-24 | 2020-06-24 | ファイザー・インク | Pyrazolopyrimidine compounds |
| DK3177624T3 (en) | 2014-08-06 | 2019-07-01 | Pfizer | IMIDAZOPYRIDAZINE COMPOUNDS |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0752853B1 (en) * | 1993-03-10 | 2005-09-21 | Smithkline Beecham Corporation | Human brain phosphodiesterase |
| JP2002531063A (en) * | 1998-10-23 | 2002-09-24 | ローゲル ニッシェ | Methods for diagnosing or prognosing Alzheimer's disease |
| FR2828693B1 (en) * | 2001-08-14 | 2004-06-18 | Exonhit Therapeutics Sa | NEW MOLECULAR TARGET OF NEUROTOXICITY |
| JP2005522519A (en) * | 2002-04-05 | 2005-07-28 | ユニヴァーシティ コート オブ ザ ユニヴァーシティ オブ エディンバラ | Schizophrenia-related genes |
-
2003
- 2003-10-25 WO PCT/EP2003/011881 patent/WO2004042390A2/en not_active Application Discontinuation
- 2003-10-25 AU AU2003283303A patent/AU2003283303A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| AU2003283303A8 (en) | 2004-06-07 |
| WO2004042390A2 (en) | 2004-05-21 |
| WO2004042390A3 (en) | 2004-09-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2003251471A1 (en) | Diagnostics and therapeutics for diseases associated with human cxc chemokine receptor 5(cxcr5) | |
| AU2003276220A1 (en) | Diagnostics and therapeutics for diseases associated with human phosphodiesterase 2a (pde2a) | |
| AU2003270037A1 (en) | Methods for measuring kinase activity and phosphatase activity | |
| AU2003301894A1 (en) | Diagnostics and therapeutics for diseases associated with human phosphodiesterase 4d (pde4d) | |
| AU2003238339A1 (en) | Diagnostics and therapeutics for diseases associated with a new human 5-ht6 receptor | |
| AU2003229735A1 (en) | Diagnostics and therapeutics for diseases associated with oxytocin receptor (oxtr) | |
| AU2003283303A1 (en) | Diagnostics and therapeutics for diseases associated with human phosphodiesterase 4b (pde4b) | |
| AU2003276136A1 (en) | Diagnostics and therapeutics for diseases associated with human mas-related gene x1 (mrgx1) | |
| AU2003274083A1 (en) | Diagnostics and therapeutics for diseases associated with human phosphodiesterase 10a (pde10a) | |
| AU2003205627A1 (en) | Diagnostics and therapeutics for diseases associated with gpr72 | |
| AU2003294728A1 (en) | DIAGNOSTICS AND THERAPEUTICS FOR DISEASES ASSOCIATED WITH HUMAN PHOSPHODIESTERASE 9a2 (PDE9a2) | |
| AU2003279361A1 (en) | DIAGNOSTICS AND THERAPEUTICS FOR DISEASES ASSOCIATED WITH HUMAN PHOSPHODIESTERASE 7B (PDE7b) | |
| AU2003267380A1 (en) | Diagnostics and therapeutics for diseases associated with human phosphodiesterase 11a (pde11a) | |
| AU2003283427A1 (en) | Diagnostics and therapeutics for diseases associated with phosphodiesterase 9a1 (pde9a1) | |
| AU2003288158A1 (en) | Diagnostics and therapeutics for diseases associated with human phosphodiesterase 4c (pde4c) | |
| AU2003288171A1 (en) | Diagnostics and therapeutics for diseases associated with human phosphodiesterase 9a3 (pde9a3) | |
| AU2003279323A1 (en) | Diagnostics and therapeutics for diseases associated with human phosphodiesterase 8b (pde8b) | |
| AU2003289894A1 (en) | Diagnostics and therapeutics for diseases associated with human phosphodiesterase 9a4 (pde9a4) | |
| AU2003282087A1 (en) | DIAGNOSTICS AND THERAPEUTICS FOR DISEASES ASSOCIATED WITH HUMAN PHOSPHODIESTERASE 7A1 (PDE7a1) | |
| AU2003274082A1 (en) | Diagnostics and therapeutics for diseases associated with human phosphodiesterase 4a (pde4a) | |
| AU2003276187A1 (en) | Diagnostics and therapeutics for diseases associated with human phosphodiesterase 8a (pde8a) | |
| AU2003283302A1 (en) | Diagnostics and therapeutics for diseases associated with human phosphodiesterase 11a1 (pde11a1) | |
| AU2003279322A1 (en) | Diagnostics and therapeutics for diseases associated with human phosphodiesterase 11a3 (pde11a3) | |
| AU2003301913A1 (en) | DIAGNOSTICS AND THERAPEUTICS FOR DISEASES ASSOCIATED WITH HUMAN PHOSPHODIESTERASE 7A2 (PDE7a2) | |
| AU2003218638A1 (en) | Diagnostics and therapeutics for diseases associated with neuromedin u1 receptor (nmu1) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |